Acquired chemoresistance in pancreatic carcinoma cells: induced secretion of IL-1β and NO lead to inactivation of caspases

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Oncogene

• Publication date

  2006-06-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1209423PMID 16474845
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells.

  2005cited by this paper
• The role of apoptosis in cancer development and treatment response

  2005cited by this paper
• Nitric oxide inhibits myocardial apoptosis by preventing caspase-3 activity via S-nitrosylation.

  2005cited by this paper
• Interleukin-1β maintains an apoptosis-resistant phenotype in the blast cells of acute myeloid leukaemia via multiple pathways

  2004cited by this paper
• Identification of Genes with Differential Expression in Acquired Drug-Resistant Gastric Cancer Cells Using High-Density Oligonucleotide Microarrays

  2004cited by this paper
• Tumor Stroma Interactions Induce Chemoresistance in Pancreatic Ductal Carcinoma Cells Involving Increased Secretion and Paracrine Effects of Nitric Oxide and Interleukin-1β

  2004influential reference
• Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas

  2004cited by this paper
• Hypoxia-Mediated Down-Regulation of Bid and Bax in Tumors Occurs via Hypoxia-Inducible Factor 1-Dependent and -Independent Mechanisms and Contributes to Drug Resistance

  2004cited by this paper
• Therapeutic potential of antisense Bcl‐2 as a chemosensitizer for cancer therapy

  2004cited by this paper
• Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death.

  2003cited by this paper
• Usage of the NF‐κB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer

  2003cited by this paper
• Role of NF-κB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death

  2003cited by this paper
• Mitochondria-targeting therapeutic strategies for overcoming chemoresistance and progression of cancer.

  2003cited by this paper
• Apoptosis and melanoma chemoresistance

  2003cited by this paper
• Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines.

  2002cited by this paper
• Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin

  2002cited by this paper
• Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase.

  2002cited by this paper
• Regulation of apoptosis by nitrosative stress.

  2002cited by this paper
• Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis.

  2001cited by this paper
• Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial.

  2001cited by this paper
• Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin

  2001influential reference
• Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia

  2000cited by this paper
• NF-κB/Rel/IκB: Implications in gastrointestinal diseases

  2000cited by this paper
• NF-kappaB/rel/IkappaB: implications in gastrointestinal diseases.

  2000cited by this paper
• Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia.

  2000cited by this paper
• In vitro modulation of cisplatin resistance by cytokines.

  1999cited by this paper
• Immune Escape of Tumors in Vivo by Expression of Cellular Flice-Inhibitory Protein

  1999influential reference
• Cytotoxic drugs and the CD95 pathway

  1999cited by this paper
• The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.

  1999cited by this paper
• The putative apoptosis inhibitor IEX-1L is a mutant nonspliced variant of p22(PRG1/IEX-1) and is not expressed in vivo.

  1999cited by this paper
• Palliative therapy for pancreatic cancer.

  1998cited by this paper
• Pancreatic cancer.

  1998cited by this paper
• Treatment of advanced and metastatic pancreatic cancer.

  1998cited by this paper
• Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation.

  1997influential reference
• Cancer statistics, 1997

  1997cited by this paper
• Treatment and survival in 13560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: An epidemiological study

  1995cited by this paper
• Redox signaling: nitrosylation and related target interactions of nitric oxide.

  1994influential reference
• p53 and K-RAS alterations in pancreatic epithelial cell lesions.

  1993cited by this paper
• Associate editor: H. Bönisch

  year unknowncited by this paper

• Inflammation, microbiota, and pancreatic cancer

  2025cites this paper
• Chemotherapy Induces an IL1β-dependent Neutrophil Recruitment that Promotes Chemoresistance in Metastatic Ovarian Cancer

  2025cites this paper
• Predict value of tumor markers combined with interleukins for therapeutic efficacy and prognosis in ovarian cancer patients.

  2024cites this paper
• Targeting HSP47 for cancer treatment

  2024cites this paper
• The role of L1CAM as predictor of poor prognosis in stage I endometrial cancer: a systematic review and meta-analysis

  2023cites this paper
• Combined dandelion extract and all-trans retinoic acid induces cytotoxicity in human breast cancer cells

  2023cites this paper
• Extracellular Vesicle-Mediated IL-1 Signaling in Response to Doxorubicin Activates PD-L1 Expression in Osteosarcoma Models

  2022cites this paper
• Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer

  2021cites this paper
• First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumours

  2021cites this paper
• Heat shock protein 47 confers chemoresistance on pancreatic cancer cells by interacting with calreticulin and IRE1α

  2021cites this paper
• Dibutyltin alters immune cell production of the pro‐inflammatory cytokines interleukin (IL) 1β and IL‐6: role of mitogen‐activated protein kinases and changes in mRNA

  2020cites this paper
• Inflammasome Sensor NLRP1 Confers Acquired Drug Resistance to Temozolomide in Human Melanoma

  2020cites this paper
• Macrophages in pancreatic cancer: An immunometabolic perspective.

  2020cites this paper
• Tumour Cell Secretome in Chemoresistance and Tumour Recurrence.

  2020cites this paper
• Electrochemotherapy Causes Caspase-Independent Necrotic-Like Death in Pancreatic Cancer Cells

  2019cites this paper
• Redox inhibition of protein phosphatase PP2A: Potential implications in oncogenesis and its progression

  2019cites this paper
• Synthesis of interleukin 1 beta and interleukin 6 in human lymphocytes is stimulated by tributyltin

  2018cites this paper
• Role of Inflammasomes in the Development of Gastrointestinal Diseases.

  2018cites this paper
• Secondary Metabolites of Mine Waste Acidophilic Fungi

  2017cites this paper
• Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK

  2017cites this paper
• Dibutyltin‐induced alterations of interleukin 1beta secretion from human immune cells

  2017cites this paper
• NO• and Pancreatic Cancer: A Complex Interaction with Therapeutic Potential

  2017cites this paper
• Anti-cancer Mechanism of Docosahexaenoic Acid in Pancreatic Carcinogenesis: A Mini-review

  2017cites this paper
• Interleukin-1β and -6 release from immune cells by DOPA-based melanin as free pigment or complexed to carboxymethylcellulose

  2017cites this paper
• Tetrabromobisphenol A and hexabromocyclododecane alter secretion of IL-1β from human immune cells

  2016cites this paper
• 16. The relationship between cholesterol metabolism and inflammation in chronic disease

  2016cites this paper
• Nitric oxide mediates metabolic coupling of omentum-derived adipose stroma to ovarian and endometrial cancer cells.

  2015cites this paper
• Tributyltin alters secretion of interleukin 1 beta from human immune cells

  2015cites this paper
• Inducible nitric oxide inhibitor enhances the anti-tumor effect of cisplatin on CNE-2 cells by inducing cell apoptosis.

  2014cites this paper
• L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: pooled PORTEC trial results.

  2014cites this paper
• Bioactive Secondary Metabolites from Acid Mine Waste Extremophiles

  2014cites this paper
• Identification of novel inflammatory serum biomarker signatures associated with pancreatic cancer and molecular characterization of antitumour agents over proliferation and apoptosos in vitro

  2014cites this paper
• Targeting apoptosis pathways in pancreatic cancer.

  2013cites this paper
• Bioprospecting in the Berkeley Pit: The Use of Signal Transduction Enzyme Inhibition Assays to Isolate Bioactive Secondary Metabolites from the Extremophilic Fungi of an Acid Mine Waste Lake

  2013cites this paper
• Tumor cells upregulate normoxic HIF-1α in response to doxorubicin.

  2013influential citation
• L1 cell adhesion molecule and epidermal growth factor receptor activation confer cisplatin resistance in intrahepatic cholangiocarcinoma cells.

  2012cites this paper
• Gene expression profiling and pathway analysis identify the integrin signaling pathway to be altered by IL-1β in human pancreatic cancer cells: role of JNK.

  2012cites this paper
• Caspase-1 inhibitors from an extremophilic fungus that target specific leukemia cell lines.

  2012cites this paper
• The neural adhesion molecule L1CAM confers chemoresistance in human glioblastomas.

  2012cites this paper
• Linking L1CAM-mediated signaling to NF-κB activation.

  2011cites this paper
• Elevated L 1 CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma

  2010cites this paper
• Nitric oxide and pancreatic cancer pathogenesis, prevention, and treatment.

  2010cites this paper
• Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma.

  2010cites this paper
• Der Einfluss von Pankreasmyofibroblasten auf die intrinsische Chemoresistenz des Pankreaskarzinoms : epigenetische Regulation von Caspasen in der pankreatischen Gangzelllinie HPDE6C7

  2009cites this paper
• Constitutively Active Inflammasome in Human Melanoma Cells Mediating Autoinflammation via Caspase-1 Processing and Secretion of Interleukin-1β*

  2009cites this paper
• alpha5-integrin is crucial for L1CAM-mediated chemoresistance in pancreatic adenocarcinoma.

  2009cites this paper
• NF-κ B as a Molecular Target in the Therapy of Pancreatic Carcinoma

  2008cites this paper
• Role of myofibroblasts in innate chemoresistance of pancreatic carcinoma—Epigenetic downregulation of caspases

  2008cites this paper
• Mononuclear cell-derived interleukin-1 beta confers chemoresistance in pancreatic cancer cells by upregulation of cyclooxygenase-2.

  2008cites this paper
• Review. Molecular background of chemoresistance in pancreatic cancer.

  2007cites this paper
• Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells

  2007cites this paper
• Confluence-dependent resistance to doxorubicin in human MDA-MB-231 breast carcinoma cells requires hypoxia-inducible factor-1 activity.

  2007cites this paper
• Molecular Background of Chemoresistance in Pancreatic Cancer

  2007cites this paper
• Role of transporters in pancreatic cancer drug resistance

  2007cites this paper
• Antioxidants and inhibitors of flavoprotein-dependent oxidases abrogate TGF-beta induction of biglycan: Evidence for a role of reactive oxygen species

  2006cites this paper
• The role of nitric oxide in mediating tumour blood flow

  2006cites this paper
• Therapeutic potential of nitric oxide in cancer.

  2006cites this paper